ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 742,09
2,33%
Dow Jones
42 205,30
0,69%
DAX
19 238,36
1,67%
Brent Oil
71,025
-2,96%
Bitcoin
65 149,46
3,20%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Amgen Inc (AMGN)

  7. Amgen Inc (AMGN) Actualités

AMGN

Amgen (AMGN)

Amgen Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AMGN
DateHeureSourceTitreSymboleSociété
25/09/202422h45IH Market NewsDow, S&P Come Off Record Highs, Close On Weak NoteNASDAQ:AMGNAmgen Inc
24/09/202422h00PR Newswire (US)TEPEZZA® (TEPROTUMUMAB) RECEIVES APPROVAL IN JAPAN FOR THE TREATMENT OF ACTIVE THYROID EYE DISEASENASDAQ:AMGNAmgen Inc
23/09/202422h00PR Newswire (US)AMGEN TO HOST CONFERENCE CALL TO DISCUSS NEW TOPLINE DATA IN INFLAMMATION AND RARE DISEASENASDAQ:AMGNAmgen Inc
13/09/202415h00PR Newswire (US)AMGEN TO PRESENT DATA FROM MULTIPLE EARLY-STAGE CLINICAL TRIALS AT ESMO 2024NASDAQ:AMGNAmgen Inc
09/09/202415h00PR Newswire (US)AMGEN PRESENTS NEW DATA FOR FIRST-IN-CLASS IMDELLTRA™ (TARLATAMAB-DLLE) IN SMALL CELL LUNG CANCER AT WCLC 2024NASDAQ:AMGNAmgen Inc
30/08/202422h00PR Newswire (US)AMGEN TO PRESENT AT THE 2024 WELLS FARGO HEALTHCARE CONFERENCENASDAQ:AMGNAmgen Inc
29/08/202422h00PR Newswire (US)AMGEN TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCENASDAQ:AMGNAmgen Inc
23/08/202422h20Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AMGNAmgen Inc
20/08/202415h00PR Newswire (US)OTEZLA® (APREMILAST) NOW AVAILABLE IN THE U.S. FOR MODERATE TO SEVERE PEDIATRIC PLAQUE PSORIASISNASDAQ:AMGNAmgen Inc
13/08/202423h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
07/08/202411h42IH Market NewsNovo Nordisk Adjusts Outlook, Airbnb Drops 16% on Declining U.S. Demand, Lumen Technologies Surges 48% in PremarketNASDAQ:AMGNAmgen Inc
06/08/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMGNAmgen Inc
06/08/202422h01PR Newswire (US)AMGEN REPORTS SECOND QUARTER 2024 FINANCIAL RESULTSNASDAQ:AMGNAmgen Inc
06/08/202411h49IH Market NewsUS Index Futures Rise After Market Sell-off, Oil Prices Trim LossesNASDAQ:AMGNAmgen Inc
02/08/202422h00PR Newswire (US)AMGEN ANNOUNCES 2024 THIRD QUARTER DIVIDENDNASDAQ:AMGNAmgen Inc
01/08/202422h00PR Newswire (US)AMGEN ANNOUNCES WEBCAST OF 2024 SECOND QUARTER FINANCIAL RESULTSNASDAQ:AMGNAmgen Inc
31/07/202412h01IH Market NewsUS Index Futures Up Ahead of Fed Decision; Oil Prices Surge Amid Middle East TensionsNASDAQ:AMGNAmgen Inc
14/06/202422h21PR Newswire (US)FDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN THE CONSOLIDATION PHASENASDAQ:AMGNAmgen Inc
12/06/202423h23Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AMGNAmgen Inc
12/06/202415h00PR Newswire (US)AMGEN TO PRESENT INNOVATIVE RHEUMATOLOGY RESEARCH AT EULAR 2024NASDAQ:AMGNAmgen Inc
05/06/202422h00PR Newswire (US)AMGEN TO PRESENT AT GOLDMAN SACHS 45TH ANNUAL GLOBAL HEALTHCARE CONFERENCENASDAQ:AMGNAmgen Inc
05/06/202415h00PR Newswire (US)AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 REGISTRATIONAL TRIAL EVALUATING UPLIZNA® (INEBILIZUMAB-CDON) FOR TREATMENT OF IMMUNOGLOBULIN G4-RELATED DISEASE (IgG4-RD)NASDAQ:AMGNAmgen Inc
05/06/202401h22Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
03/06/202422h00PR Newswire (US)AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCENASDAQ:AMGNAmgen Inc
28/05/202415h00PR Newswire (US)AMGEN TO PRESENT INNOVATIVE RESEARCH FROM ITS ROBUST ONCOLOGY PORTFOLIO AT ASCO 2024NASDAQ:AMGNAmgen Inc
19/05/202423h15PR Newswire (US)NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE® TO HELP PATIENTS LIVING WITH COPDNASDAQ:AMGNAmgen Inc
17/05/202400h46PR Newswire (US)FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCERNASDAQ:AMGNAmgen Inc
16/05/202400h45PR Newswire (US)AMGEN TO HOST CONFERENCE CALL FOLLOWING ATS 2024NASDAQ:AMGNAmgen Inc
10/05/202422h02Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AMGNAmgen Inc
09/05/202422h00PR Newswire (US)AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCENASDAQ:AMGNAmgen Inc
 Showing the most relevant articles for your search:NASDAQ:AMGN

Dernières Valeurs Consultées

TSX
IDG
Indigo Books and Music
NYSE
WWE
World Wrestling Entertai...
BOV
DXCO3M
Dexco ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés